Lattice Semiconductor (NASDAQ:LSCC – Get Free Report) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided earnings per share guidance of $0.15 to $0.23 for the period, compared to the consensus earnings per share estimate of $0.26. The company issued revenue guidance of $112 million to $122 million, compared to the consensus revenue estimate of $132.02 million. Lattice Semiconductor also updated its Q4 2024 guidance to EPS.
Analyst Upgrades and Downgrades
LSCC has been the topic of a number of research analyst reports. Stifel Nicolaus raised shares of Lattice Semiconductor from a “hold” rating to a “buy” rating and set a $55.00 price target on the stock in a report on Tuesday, September 17th. Susquehanna reduced their target price on shares of Lattice Semiconductor from $85.00 to $65.00 and set a “positive” rating for the company in a research report on Tuesday, July 30th. Benchmark reaffirmed a “buy” rating and issued a $60.00 price target on shares of Lattice Semiconductor in a report on Monday, September 16th. StockNews.com downgraded Lattice Semiconductor from a “hold” rating to a “sell” rating in a research note on Saturday, August 3rd. Finally, Needham & Company LLC reissued a “buy” rating and issued a $61.00 target price on shares of Lattice Semiconductor in a research report on Tuesday, September 17th. Two equities research analysts have rated the stock with a sell rating, ten have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $63.08.
Read Our Latest Research Report on LSCC
Lattice Semiconductor Stock Down 0.7 %
Insider Activity
In other news, SVP Mark Jon Nelson sold 1,232 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $48.98, for a total value of $60,343.36. Following the completion of the transaction, the senior vice president now directly owns 14,919 shares in the company, valued at approximately $730,732.62. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Lattice Semiconductor news, SVP Mark Jon Nelson sold 1,232 shares of the stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $48.98, for a total value of $60,343.36. Following the sale, the senior vice president now directly owns 14,919 shares in the company, valued at $730,732.62. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Sherri R. Luther sold 20,632 shares of the business’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $48.89, for a total transaction of $1,008,698.48. Following the transaction, the chief financial officer now owns 90,341 shares of the company’s stock, valued at $4,416,771.49. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.80% of the company’s stock.
Lattice Semiconductor Company Profile
Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor products in Asia, Europe, and the Americas. The company offers field programmable gate arrays that consist of four product families, including the Lattice Certus and ECP, Mach, iCE, and CrossLink. It also provides video connectivity application specific standard products.
See Also
- Five stocks we like better than Lattice Semiconductor
- What Investors Need to Know to Beat the Market
- Intel: Is Now the Time to Be Brave?Â
- Most Volatile Stocks, What Investors Need to Know
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Differences Between Momentum Investing and Long Term Investing
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Lattice Semiconductor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lattice Semiconductor and related companies with MarketBeat.com's FREE daily email newsletter.